Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07009509 · ClinicalTrials.gov registry record · NA
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
A NA study of Nicotine Vaping, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 1,166
- Enrollment target
- 1
- Study location
NCT07009509 is a NA study of Nicotine Vaping that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 1,166 participants, above the 117-participant average among 5 other Nicotine Vaping trials with a reported enrollment target (897% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07009509, a NA study of Nicotine Vaping, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,166 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot study is to determine the feasibility of a randomized trial of the YES-CAN! (Youth Engaged Strategies to Change Adolescent Norms) program to prevent nicotine vaping among adolescents. The program integrates the following evidence-based strategies: youth-adult collaboration; youth-developed narrative videos to convey health messages; peer leaders as change agents; and sustained implementation to change the normative environment. Two middle/high school communities will receive the YES-CAN! intervention. In each school community, a trained teacher will deliver a credit-earning middle or high school class to 25-30 middle or high school students, who will produce 6-8 short videos intended to increase refusal skills; promote stress management and positive coping; change social norms; prevent vaping initiation; and promote vaping cessation among current users. Videos will use a narrative approach and integrate known determinants of vaping. Middle or high school students will collaborate with the teacher and researchers to develop discussion guides and skills-building activities based on best practices for substance use prevention. In 6-8 sessions, middle or high school students will deliver their videos to all students in the associated middle school. A text messaging or other media component will reinforce and boost the effectiveness of the classroom sessions. Aims for this pilot/feasibility study are: 1. To determine the feasibility and acceptability of implementing the YES-CAN! program 2. To determine the feasibility and acceptability of the research protocols that will be used in a future efficacy trial
Conditions Studied
Interventions
- BEHAVIORAL YES-CAN! program
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,166 participants |
| Start Date | 2024-08-15 |
| Est. Completion | 2026-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07009509
The ClinicalTrials.gov registry entry for NCT07009509 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,166 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 117-participant average among 5 other Nicotine Vaping trials with a reported enrollment target (897% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nicotine Vaping appearing as the primary indexed condition, and to 1 intervention - of which YES-CAN! program is the first listed.
NCT07009509 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT07009509 about?
NCT07009509 is a clinical study titled "Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping". The goal of this pilot study is to determine the feasibility of a randomized trial of the YES-CAN! (Youth Engaged Strategies to Change Adolescent Norms) program to prevent nicotine vaping among adolescents. The program integrates the following evidence-based strategies: youth-adult collaboration; yo...
What is the current status of trial NCT07009509?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,166 participants. The study started on 2024-08-15. Estimated completion is 2026-10-30.
What conditions does trial NCT07009509 study?
This clinical trial studies the following conditions: Nicotine Vaping.
What interventions are being tested in trial NCT07009509?
The interventions under investigation include: YES-CAN! program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07009509?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07009509 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Vaping
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nicotine Flux, a Potentially Powerful Tool for Regulating Nicotine Delivery From Electronic Cigarettes
COMPLETED · NA
-
Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes
COMPLETED · NA
-
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
RECRUITING · Phase 1
-
Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine
RECRUITING · Phase 1
-
Kick-Nic! Youth Quit Vaping App
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.